I fully agree here. I am invested because the science is great and I desperately want to see an efficacious drug available that addresses AD, especially since my partner's father has a family history with AD and I want this to be available to treat him (unfortunately, we're US-based). I was merely responding to your statement that a CMA is just a delay in maximizing value because I imagine some on this board would interpret "value" as monetary (not social) value, and so wanted to explain my thought process.
For social value, I really hope they can collect whatever evidence is needed in an expeditious manner so we can roll this out en masse. We know from the early start analysis that every month is important for combating AD.
Market Data 
Markets 
